«There are limited treatment options for patients with high - risk type 1 diabetes to manage life -
threatening hypoglycemic episodes,» said Paul Laikind, PhD, President and Chief Executive Officer of ViaCyte.
But some patients suffer life -
threatening hypoglycemic episodes, and the disease has other serious health consequences.
Not exact matches
The PEC - Direct product candidate is being developed for patients with high - risk type 1 diabetes, who often experience life -
threatening acute complications, such as hypoglycemia unawareness and severe
hypoglycemic episodes.
This is especially true for the patients with high - risk type 1 diabetes, who face challenges such as hypoglycemia unawareness and life -
threatening severe
hypoglycemic episodes.